Boston Scientific Corp (BSX):企業の財務・戦略的SWOT分析

◆英語タイトル:Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME519FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Boston Scientific Corp (BSX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Boston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia, Puerto Rico and Switzerland. It sells products directly and also through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Boston Scientific Corp Key Recent Developments

Mar 26,2021: Boston Scientific Announces Conference Call Discussing First Quarter 2021 Results and Participation in Truist Securities 2021 Life Sciences Summit
Mar 24,2021: Boston Scientific to pay US states for deceptive mesh devices marketing
Mar 04,2021: Boston Scientific to acquire Lumenis’ surgical business for $1.07bn
Mar 03,2021: Baring Private Equity Asia Announces Agreement to Sell Lumenis’ Surgical Business to Boston Scientific for USD1.07 billion
Feb 12,2021: Boston Scientific Announces February and March 2021 Conference Schedule

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Boston Scientific Corp – Key Facts
Boston Scientific Corp – Key Employees
Boston Scientific Corp – Key Employee Biographies
Boston Scientific Corp – Major Products and Services
Boston Scientific Corp – History
Boston Scientific Corp – Company Statement
Boston Scientific Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Boston Scientific Corp – Business Description
Business Segment: Cardiovascular
Overview
Performance
Business Segment: MedSurg
Overview
Performance
Business Segment: Rhythm and Neuro
Overview
Performance
Business Segment: Specialty Pharmaceuticals
Overview
Performance
Geographical Segment: APAC (Asia-Pacific)
Performance
Geographical Segment: EMEA (Europe, Middle East and Africa)
Performance
Geographical Segment: International
Performance
Geographical Segment: LACA (Latin America and Canada)
Performance
Geographical Segment: U.S.
Performance
R&D Overview
Boston Scientific Corp – Corporate Strategy
Boston Scientific Corp – SWOT Analysis
SWOT Analysis – Overview
Boston Scientific Corp – Strengths
Boston Scientific Corp – Weaknesses
Boston Scientific Corp – Opportunities
Boston Scientific Corp – Threats
Boston Scientific Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Boston Scientific Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Boston Scientific Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Boston Scientific Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 26, 2021: Boston Scientific Announces Conference Call Discussing First Quarter 2021 Results and Participation in Truist Securities 2021 Life Sciences Summit
Mar 24, 2021: Boston Scientific to pay US states for deceptive mesh devices marketing
Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
Feb 03, 2021: Boston Scientific announces results for fourth quarter and full year 2020
Jan 12, 2021: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2020
Dec 14, 2020: Boston Scientific announces stipulation of dismissal of Nevro Corporation’s patent infringement case in California
Dec 02, 2020: Boston Scientific to sell BTG Specialty Pharmaceuticals business for $800m
Oct 28, 2020: Boston Scientific announces results for third quarter 2020
Sep 21, 2020: Boston Scientific signs agreement with option to acquire Farapulse
Aug 03, 2020: Boston Scientific: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Boston Scientific Corp, Key Facts
Boston Scientific Corp, Key Employees
Boston Scientific Corp, Key Employee Biographies
Boston Scientific Corp, Major Products and Services
Boston Scientific Corp, History
Boston Scientific Corp, Other Locations
Boston Scientific Corp, Subsidiaries
Boston Scientific Corp, Key Competitors
Boston Scientific Corp, Ratios based on current share price
Boston Scientific Corp, Annual Ratios
Boston Scientific Corp, Annual Ratios (Cont...1)
Boston Scientific Corp, Annual Ratios (Cont...2)
Boston Scientific Corp, Interim Ratios
Boston Scientific Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Boston Scientific Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Boston Scientific Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Boston Scientific Corp (BSX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Wesfarmers Ltd (WES)-石油・ガス分野:企業M&A・提携分析
    Summary Wesfarmers Limited (Wesfarmers) is a diversified company that has business operations in retail and industrial activities. Its retail activities include supermarkets, liquor, hotels and convenience stores; department stores; home improvement and office supplies; and apparel retailing. The co …
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • CEZ Group:電力:M&Aディール及び事業提携情報
    Summary CEZ Group (CEZ), a subsidiary of CEZ AS, is an integrated electricity conglomerate company. The company produces and markets electricity. It generates, trades, and distributes power and heat. CEZ also provides coal mining services. The company offers services such as telecommunications, info …
  • The Procter & Gamble Co:戦略・SWOT・企業財務分析
    The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report Summary The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Coca-Cola FEMSA SAB de CV:戦略・SWOT・企業財務分析
    Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Reata Pharmaceuticals Inc (RETA):製薬・医療:M&Aディール及び事業提携情報
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • NetSuite Inc:企業の戦略的SWOT分析
    NetSuite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Oil and Natural Gas Corporation Limited:戦略・SWOT・企業財務分析
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Whirlpool Corp (WHR):企業の財務・戦略的SWOT分析
    Whirlpool Corp (WHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sirtex Medical Ltd (SRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Key Energy Services Inc (KEG):石油・ガス:M&Aディール及び事業提携情報
    Summary Key Energy Services Inc (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, fi …
  • Adverum Biotechnologies Inc (ADVM):製薬・医療:M&Aディール及び事業提携情報
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Alaska Air Group, Inc.:戦略・SWOT・企業財務分析
    Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Marathon Oil Corporation:企業の戦略・SWOT・財務情報
    Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vedanta Ltd:企業の戦略・SWOT・財務情報
    Vedanta Ltd - Strategy, SWOT and Corporate Finance Report Summary Vedanta Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • American Shared Hospital Services (AMS):企業の財務・戦略的SWOT分析
    Summary American Shared Hospital Services (ASHS) is a distributor of medical equipment to hospitals and medical centers. The company also offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning and design, s …
  • Humanwell Healthcare (Group) Co Ltd (600079):医療機器:M&Aディール及び事業提携情報
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anest …
  • Uranium One Inc:企業の戦略的SWOT分析
    Uranium One Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Software AG (SOW):企業の財務・戦略的SWOT分析
    Summary Software AG (SAG) is a technology company that provides software management solutions. The company offers digital business platform with integration, process management, adaptive application development, real-time analytics and enterprise architecture management. Its products include Adabas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆